Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Sandoz Group Ltd ( (CH:SDZ) ) has shared an announcement.
Sandoz shareholders approved all Board of Directors’ proposals at the 2026 Annual General Meeting in Basel, endorsing the 2025 financial statements and the report on non-financial matters, with 77.06% of registered shares represented. Gilbert Ghostine was re-elected as Chairman along with the full board, while KPMG was confirmed as statutory auditor and Advoro Zurich as independent proxy, signaling broad investor support for the company’s governance framework.
Investors backed a dividend of CHF 0.80 per registered dividend-paying share, equal to 27% of core net income, with payment set for April 15, 2026 and the last cum-dividend trading day on April 12. Shareholders also approved maximum aggregate compensation levels for the Board and Executive Committee and endorsed the 2025 Compensation Report, reinforcing continuity in leadership and pay structures as Sandoz pursues its strategy in the competitive global generics and biosimilars market.
The most recent analyst rating on (CH:SDZ) stock is a Hold with a CHF75.00 price target. To see the full list of analyst forecasts on Sandoz Group Ltd stock, see the CH:SDZ Stock Forecast page.
More about Sandoz Group Ltd
Sandoz Group AG is a Basel-based global leader in affordable medicines, focused on generics and biosimilars that expand patient access and generate substantial healthcare savings. With a portfolio of about 1,300 medicines spanning conditions from the common cold to cancer, the company serves over one billion patients worldwide and recorded net sales of USD 11.1 billion in 2025. Sandoz marks key milestones in 2026, including 20 years in biosimilars, 80 years of antibiotics manufacturing and 140 years of corporate heritage, underscoring its long-term role in the pharmaceutical industry.
Average Trading Volume: 829,803
Technical Sentiment Signal: Buy
Current Market Cap: CHF28.74B
Find detailed analytics on SDZ stock on TipRanks’ Stock Analysis page.